We are live on ! Find out more
CGH

Crossmark Global Holdings Portfolio holdings

AUM $7.71B
1-Year Est. Return 37.66%
This Fund
S&P 500
This Quarter Est. Return
+7.36%
1 Year Est. Return
+37.66%
3 Year Est. Return
+112.26%
5 Year Est. Return
+139.33%
10 Year Est. Return
AUM
$4.25B
AUM Growth
+$237M
Cap. Flow
+$37.5M
Cap. Flow %
0.88%
Top 10 Hldgs %
14.79%
Holding
1,330
New
78
Increased
604
Reduced
560
Closed
34

Top Sells

Rank Stock Value
1
TRI icon
Thomson Reuters
TRI
+$13.3M
2
ABBV icon
AbbVie
ABBV
+$12.9M
3
SBUX icon
Starbucks
SBUX
+$11.8M
4
NMR icon
Nomura Holdings
NMR
+$11.3M
5
EMR icon
Emerson Electric
EMR
+$10.6M

Sector Composition

Rank Sector Weight
1 Technology 25.14%
2 Financials 14.2%
3 Healthcare 12.1%
4 Consumer Discretionary 11%
5 Industrials 8.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EXP icon
576
Eagle Materials
EXP
$6.57B
$1.04M 0.02%
7,072
+4,015
+131% +$569K
TCOM icon
577
Trip.com Group
TCOM
$29.1B
$1.03M 0.02%
27,342
+4,516
+20% +$168K
APA icon
578
APA Corp
APA
$13.2B
$1.03M 0.02%
28,472
-2,219
-7% -$89K
LSI
579
DELISTED
Life Storage, Inc.
LSI
$1.02M 0.02%
7,789
+312
+4% +$36.1K
HSIC icon
580
Henry Schein
HSIC
$9.82B
$1.02M 0.02%
12,502
-240
-2% -$19.6K
WAB icon
581
Wabtec
WAB
$49.3B
$1.02M 0.02%
10,089
+170
+2% +$17.4K
HBAN icon
582
Huntington Bancshares
HBAN
$35.5B
$1.02M 0.02%
90,931
+31,119
+52% +$433K
NOC icon
583
Northrop Grumman
NOC
$81.2B
$1.01M 0.02%
2,197
-195
-8% -$90.5K
BAM icon
584
Brookfield Asset Management
BAM
$83.8B
$1M 0.02%
30,692
+15,094
+97% +$490K
RPM icon
585
RPM International
RPM
$15B
$991K 0.02%
11,358
-100
-0.9% -$8.76K
GSK icon
586
GSK
GSK
$106B
$990K 0.02%
27,819
+282
+1% +$9.87K
ARE icon
587
Alexandria Real Estate Equities
ARE
$8.56B
$985K 0.02%
7,839
-48
-0.6% -$7.05K
UTHR icon
588
United Therapeutics
UTHR
$23.1B
$983K 0.02%
4,390
+134
+3% +$33K
FE icon
589
FirstEnergy
FE
$27.5B
$976K 0.02%
24,365
-467
-2% -$18.9K
SCCO icon
590
Southern Copper
SCCO
$166B
$974K 0.02%
13,773
-581
-4% -$39.5K
ASO icon
591
Academy Sports + Outdoors
ASO
$2.98B
$971K 0.02%
14,872
-249
-2% -$14.7K
RGLD icon
592
Royal Gold
RGLD
$19.5B
$971K 0.02%
7,491
+172
+2% +$21.2K
FMS icon
593
Fresenius Medical Care
FMS
$12.9B
$969K 0.02%
45,597
-945
-2% -$18.1K
FIVE icon
594
Five Below
FIVE
$13.5B
$963K 0.02%
4,678
+319
+7% +$62.8K
DPZ icon
595
Domino's
DPZ
$11.6B
$955K 0.02%
2,893
+168
+6% +$55.9K
NBIX icon
596
Neurocrine Biosciences
NBIX
$16.6B
$953K 0.02%
9,415
+212
+2% +$22.1K
SLAB icon
597
Silicon Laboratories
SLAB
$7.23B
$952K 0.02%
5,435
+47
+0.9% +$7.9K
HQY icon
598
HealthEquity
HQY
$8.75B
$950K 0.02%
16,190
+44
+0.3% +$2.67K
TRMB icon
599
Trimble
TRMB
$13.9B
$945K 0.02%
18,023
+957
+6% +$51.1K
TDY icon
600
Teledyne Technologies
TDY
$32B
$943K 0.02%
2,109
+51
+2% +$21.6K

Similar funds

Crossmark Global Holdings's Q1 2023 Portfolio in Review

As of Q1 2023, Crossmark Global Holdings held 1,330 positions worth $4.25B, up 5.9% from $4.01B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Crossmark Global Holdings's Q1 2023 filing shows 78 new, 604 increased, 560 reduced and 34 closed positions. Its largest new stake was Bunge Global: 122,662 shares worth $11.7M. The largest sale was Thomson Reuters, an estimated $13.3M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • Crossmark Global Holdings's largest Q1 2023 buy was Bunge Global: 122,662 shares worth $11.7M.
  • Crossmark Global Holdings added most to Lowe's Companies in Q1 2023, an estimated $15M increase.
  • Crossmark Global Holdings's biggest Q1 2023 reduction was Thomson Reuters, cutting an estimated $13.3M.
  • Crossmark Global Holdings fully exited Canon, Inc. in Q1 2023, selling an estimated $2.25M.
  • Crossmark Global Holdings's ten largest holdings make up 15% of its $4.25B portfolio in Q1 2023.
  • Crossmark Global Holdings opened 78 new positions and closed 34 in Q1 2023.
  • Crossmark Global Holdings's portfolio value rose 5.9% quarter-over-quarter to $4.25B.

Based on Crossmark Global Holdings's 13F filing for Q1 2023, filed 12 May 2023.